From: RelB plays an oncogenic role and conveys chemo-resistance to DLD-1 colon cancer cells
Characteristics | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95%) CI | p value | HR (95%) CI | p value | |
Age (≥ 60 vs. < 60) | 1.525 (0.838–2.776) | 0.167 |  |  |
Gender (male vs. female) | 0.835 (0.487–1.432) | 0.512 |  |  |
Site (right vs. left) | 0.738 (0.415–1.312) | 0.738 |  |  |
Differentiation (poor vs. well, moderate) | 3.034 (1.664–5.533) | < 0.001*** | 2.115 (1.044–4.286) | 0.038* |
T stage (T4 vs. T2, T3) | 1.574 (0.804–3.079) | 0.186 |  |  |
N stage (N1, N2 vs. N0) | 2.725 (1.550–4.793) | 0.001*** |  |  |
M stage (M1 vs. M0) | 2.725 (1.550–4.793) | 0.001*** |  |  |
pTNM stage (III, IV vs. I, II) | 2.916 (1.635–5.201) | < 0.001*** |  |  |
RelB expression (high vs. low) | 2.657 (1.438–4.907) | 0.002** | 2.996 (1.484–6.047) | 0.002** |